Copilots assist users; agents execute tasks. Confusing them in pharma AI creates real risks for governance, validation, and regulatory compliance.

Evals bring structure to pharma AI, enabling teams to measure performance, ensure consistency, and apply quality principles already familiar in regulated systems.

AI can cut medical content timelines from weeks to hours. But the FDA’s rules haven’t changed, companies remain accountable for every word.